Diagnostic accuracy of LAMP versus PCR over the course of SARS-CoV-2 infection.


Journal

International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases
ISSN: 1878-3511
Titre abrégé: Int J Infect Dis
Pays: Canada
ID NLM: 9610933

Informations de publication

Date de publication:
Jun 2021
Historique:
received: 08 01 2021
revised: 01 04 2021
accepted: 07 04 2021
pubmed: 17 4 2021
medline: 3 7 2021
entrez: 16 4 2021
Statut: ppublish

Résumé

Reverse transcription loop-mediated isothermal amplification (RT-LAMP) has been validated to diagnose several viral infections. However, its diagnostic accuracy in detecting SARS-CoV-2 in real-life clinical settings remains unclear. This study aimed to determine the diagnostic sensitivity and specificity of RT-LAMP compared to reverse transcription-quantitative polymerase chain reaction (RT-qPCR) over the disease course of COVID-19. A total of 124 nasopharyngeal swab samples obtained from 24 COVID-19 patients were tested by RT-LAMP and RT-qPCR. Sensitivities and specificities of RT-LAMP compared with RT-qPCR were analyzed as a function of time from onset. Up to the 9th day after onset, the RT-LAMP had a positivity of 92.8%, and the sensitivity and specificity compared with RT-qPCR was 100%. However, after the 10th day after onset, the positivity of RT-LAMP decreased to less than 25%, and the concordance of positivity between the two methods was below 60%. The limit of detection of RT-LAMP was 6.7 copies/reaction. Until the 9th day after the onset of symptoms, RT-LAMP had the same diagnostic accuracy as RT-qPCR. These findings suggest that RT-LAMP can be used as a diagnostic tool for COVID-19 as an alternative to RT-qPCR in the acute symptomatic phase of COVID-19.

Identifiants

pubmed: 33862213
pii: S1201-9712(21)00329-5
doi: 10.1016/j.ijid.2021.04.018
pmc: PMC8056478
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

195-200

Informations de copyright

Copyright © 2021 The Author(s). Published by Elsevier Ltd.. All rights reserved.

Références

Biology (Basel). 2020 Jul 22;9(8):
pubmed: 32707972
BMC Med. 2020 Nov 4;18(1):346
pubmed: 33143712
JAMA. 2020 Oct 6;324(13):1330-1341
pubmed: 32876694
Clin Microbiol Infect. 2020 Jun;26(6):773-779
pubmed: 32276116
J Pharm Anal. 2020 Apr;10(2):97-101
pubmed: 32292623
J Mol Diagn. 2020 Jun;22(6):729-735
pubmed: 32276051
Med Hypotheses. 2020 Aug;141:109786
pubmed: 32361529
Sci Transl Med. 2020 Aug 12;12(556):
pubmed: 32719001
Euro Surveill. 2020 Jan;25(3):
pubmed: 31992387
Int J Mol Sci. 2020 Jul 29;21(15):
pubmed: 32751106
J Med Microbiol. 2020 Sep;69(9):1169-1178
pubmed: 32755529
J Med Virol. 2020 Apr;92(4):401-402
pubmed: 31950516
Jpn J Infect Dis. 2020 Jul 22;73(4):304-307
pubmed: 32074516
Front Cell Infect Microbiol. 2020 Jun 16;10:331
pubmed: 32626666
Microb Biotechnol. 2020 Jul;13(4):950-961
pubmed: 32333644
Lancet. 2020 Feb 29;395(10225):689-697
pubmed: 32014114
J Med Virol. 2021 Feb;93(2):719-725
pubmed: 32706393
Viruses. 2019 Dec 23;12(1):
pubmed: 31877989
N Engl J Med. 2020 Nov 5;383(19):1813-1826
pubmed: 32445440
Proc Natl Acad Sci U S A. 2020 Sep 15;117(37):22727-22735
pubmed: 32868442
PLoS Negl Trop Dis. 2018 May 29;12(5):e0006381
pubmed: 29813062
JAMA. 2020 May 12;323(18):1843-1844
pubmed: 32159775
J Clin Virol. 2020 Nov;132:104652
pubmed: 33053493
Biometrics. 1977 Mar;33(1):159-74
pubmed: 843571

Auteurs

Masato Inaba (M)

Department of Infectious Diseases, Fujita Health University School of Medicine, Toyoake, Aichi, Japan. Electronic address: imasato@fujita-hu.ac.jp.

Yuki Higashimoto (Y)

Faculty of Medical Technology, Fujita Health University School of Health Sciences, Toyoake, Aichi, Japan.

Yoko Toyama (Y)

Department of Respiratory Medicine, Fujita Health University School of Medicine, Toyoake, Aichi, Japan.

Tomoya Horiguchi (T)

Department of Respiratory Medicine, Fujita Health University School of Medicine, Toyoake, Aichi, Japan.

Masaya Hibino (M)

Department of Emergency and General Internal Medicine, Fujita Health University School of Medicine, Toyoake, Aichi, Japan.

Mitsunaga Iwata (M)

Department of Emergency and General Internal Medicine, Fujita Health University School of Medicine, Toyoake, Aichi, Japan.

Kazuyoshi Imaizumi (K)

Department of Respiratory Medicine, Fujita Health University School of Medicine, Toyoake, Aichi, Japan.

Yohei Doi (Y)

Department of Infectious Diseases, Fujita Health University School of Medicine, Toyoake, Aichi, Japan; Division of Infectious Diseases, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH